8% Yield Improvements and 50% Cycle Time Reduction Realized by Alkermes Pharma Ireland Ltd for Challenging Product
Alkermes’ Intestinal Protective Drug Absorption System products present decided patient outcome benefits; however, key manufacturing challenges presented include:
• Excessive time required awaiting sieve analysis results
• Excessive coating activities to impart the correct dissolution profile for the product
• Variability in the manufacturing yield
Via a collaboration with Innopharma Labs, Alkermes was able to achieve 8% Yield Improvements and 50% Cycle Time Reduction along with numerous other efficiency benefits.
After completing the registration form you will have access to download the white paper in PDF format.
Author: Innopharma Labs